Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | April 04, 2012

Abortion and the Politics of Forced Ultrasound

Transvaginal scan shows embryo measuring 39.1 mm. Speech-and-display requirements in some state laws require visualization and verbal description of the embryo before women can undergo an abortion.

Increasingly in this country, diagnostic ultrasound is being used to advance a political agenda.  Last month the Virginia state legislature passed, and the governor signed, a law that, effective July 1, requires women seeking an abortion to submit to a fetal ultrasound. In Texas, not only must such an ultrasound be performed, but also the fetus must be described to the patient in terms of its heart rate, its size and the length of its limbs. North Carolina and Oklahoma have laws with similar “speech-and-display” requirements. Four other states are considering such laws. 

While the intent may be to dissuade patients from going through with a scheduled procedure, forcing fetal ultrasound exams on the medical community may have a wider and longer term effect. Given the requirements placed on them and their staff, some physicians may choose not to perform abortions, thus reducing access to these procedures. And, if clinics don’t receive reimbursement from the state or insurance for the mandated ultrasound exams, the cost of these exams may be added to the price of abortions, creating a financial barrier that weighs heaviest on low-income women.

The irony is that a technology as benign as ultrasound has been hijacked for such a purpose. The extraordinary safety of ultrasound is the reason those who specialize in women’s health make as much use of it as they do. More is the pity that a tool optimized to help women is being subverted to bully them — and that those who have sworn to protect their patients are being turned into political instruments that violate them.

Because the vast majority of abortions occur during the first 12 weeks of pregnancy, an intravaginal transducer often must be used to visualize the fetus. Laws that require such visualization, therefore, require women seeking a legal medical procedure to undergo an invasive one that they do not want and is not medically necessary.

As the momentum grows for this subversion of ultrasound, healthcare providers must decide: Will they be foot soldiers in a politically charged army or the conscience of their profession who speak out against the political use of medical technology.

Related Content

Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
DenseBreast-info.org Debuts  Spanish Language Video  About Dense Breasts
News | Breast Density | September 12, 2017
Breast cancer risks associated with breast density are the subject of a new Spanish language video launched recently by...
Asian Study Underlines Potential Value of Pressure-Guided Mammography
News | Mammography | September 11, 2017
Sigmascreening recently announced that a study of in total 15,898 in digital mammograms from 3,772 Asian women...
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
Breast imaging X-ray mammogram showing a breast tumor. Photo courtesy of Monthian Ritchan-Ad

Photo courtesy of Monthian Ritchan-Ad

Feature | Breast Density | September 08, 2017 | By Roy Prager, M.D.
While mammograms play a vital role in efforts to identify breast cancer, they can present some challenges in women with...
FDA Clears Senographe Pristina Mammography System With Patient-Assisted Compression
Technology | Mammography | September 05, 2017
The U.S. Food and Drug Administration (FDA) cleared GE Healthcare’s Senographe Pristina with Self-Compression, the...
FDA Releases Six-Month Inspection Data From EQUIP Mammography Quality Initiative
News | Mammography | September 01, 2017
September 1, 2017 — The Division of Mammography Quality Standards (DMQS) of the U.S.
Hologic Announces Availability of Brevera Breast Biopsy System With CorLumina Imaging Technology
Technology | Breast Biopsy Systems | August 31, 2017
Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging...
China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017
iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from the China Food...
Top list of stories, article, videos for breast imaging.
Feature | Breast Imaging | August 30, 2017 | Dave Fornell
August 30, 2017 — This is a list of the top breast imaging content so far for 2017.
Overlay Init